Lv71
4950 积分 2024-02-04 加入
Efficacy and safety of lebrikizumab combined with topical corticosteroids in Japanese patients with moderate-to-severe atopic dermatitis: a phase 3, double-blind, placebo-controlled, randomized clinical trial (ADhere-J)
20分钟前
已完结
Updated treatment targets in inflammatory bowel disease (STRIDE-III): an initiative of the International Organization for the Study of IBD
16天前
已关闭
Impact of Comorbid Psoriasis on the Efficacy of Ustekinumab and Mirikizumab in Inflammatory Bowel Disease: A Post-hoc Analysis of UNITI, SEAVUE, and LUCENT
28天前
已完结
Early and Sustained Comprehensive Symptom Control, Including Bowel Urgency and Fatigue, With Mirikizumab in Crohn's Disease: An Exploratory Post Hoc Analysis of the Phase 3 VIVID‐1 Study
1个月前
已完结
Intestinal Ultrasound Predicts Primary Non-Response and Maintenance Relapse in Upadacitinib-Treated Active Crohn's Disease: A Multicenter, Prospective Cohort Study
1个月前
已完结
High Incidence of Recurrent Crohn’s Disease Following Colectomy for Ulcerative Colitis Revealed with Long Follow-Up
1个月前
已完结
Beyond inflammation: the residual burden as the next target in inflammatory bowel disease
1个月前
已完结
炎症性肠病患儿青春期向成人期过渡管理实践指南（2026）
1个月前
已完结
皖公网安备34019202002308
